Literature DB >> 24108448

Automated determination of metastases in unstructured radiology reports for eligibility screening in oncology clinical trials.

Valentina I Petkov1, Lynne T Penberthy, Bassam A Dahman, Andrew Poklepovic, Chris W Gillam, James H McDermott.   

Abstract

Enrolling adequate numbers of patients that meet protocol eligibility criteria in a timely manner is critical, yet clinical trial accrual continues to be problematic. One approach to meet these accrual challenges is to utilize technology to automatically screen patients for clinical trial eligibility. This manuscript reports on the evaluation of different automated approaches to determine the metastatic status from unstructured radiology reports using the Clinical Trials Eligibility Database Integrated System (CTED). The study sample included all patients (N = 5,523) with radiologic diagnostic studies (N = 10,492) completed in a two-week period. Eight search algorithms (queries) within CTED were developed and applied to radiology reports. The performance of each algorithm was compared to a reference standard which consisted of a physician's review of the radiology reports. Sensitivity, specificity, positive, and negative predicted values were calculated for each algorithm. The number of patients identified by each algorithm varied from 187 to 330 and the number of true positive cases confirmed by physician review ranged from 171 to 199 across the algorithms. The best performing algorithm had sensitivity 94%, specificity 100%, positive predictive value 90%, negative predictive value 100%, and accuracy of 99%. Our evaluation process identified the optimal method for rapid identification of patients with metastatic disease through automated screening of unstructured radiology reports. The methods developed using the CTED system could be readily implemented at other institutions to enhance the efficiency of research staff in the clinical trials eligibility screening process.

Entities:  

Keywords:  Clinical trials; automation; eligibility screening; information extraction; metastases; radiology reports

Mesh:

Year:  2013        PMID: 24108448      PMCID: PMC4358809          DOI: 10.1177/1535370213508172

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  34 in total

1.  Evaluation of negation phrases in narrative clinical reports.

Authors:  W W Chapman; W Bridewell; P Hanbury; G F Cooper; B G Buchanan
Journal:  Proc AMIA Symp       Date:  2001

2.  Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the atlantic.

Authors:  Andrea Wang-Gillam; Kristina Williams; Silvia Novello; Feng Gao; Giorgio V Scagliotti; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

3.  Clinical utility of likelihood ratios.

Authors:  E J Gallagher
Journal:  Ann Emerg Med       Date:  1998-03       Impact factor: 5.721

4.  Extracting findings from narrative reports: software transferability and sources of physician disagreement.

Authors:  G Hripcsak; G J Kuperman; C Friedman
Journal:  Methods Inf Med       Date:  1998-01       Impact factor: 2.176

5.  Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.

Authors:  Anneke T Schroen; Gina R Petroni; Hongkun Wang; Robert Gray; Xiaofei F Wang; Walter Cronin; Daniel J Sargent; Jacqueline Benedetti; Donald L Wickerham; Benjamin Djulbegovic; Craig L Slingluff
Journal:  Clin Trials       Date:  2010-07-01       Impact factor: 2.486

Review 6.  Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials.

Authors:  Carol A Townsley; Rita Selby; Lillian L Siu
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

7.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Authors:  P N Lara; R Higdon; N Lim; K Kwan; M Tanaka; D H Lau; T Wun; J Welborn; F J Meyers; S Christensen; R O'Donnell; C Richman; S A Scudder; J Tuscano; D R Gandara; K S Lam
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

8.  Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.

Authors:  Lynne Penberthy; Richard Brown; Maureen Wilson-Genderson; Bassam Dahman; Gordon Ginder; Laura A Siminoff
Journal:  Clin Trials       Date:  2012-10-02       Impact factor: 2.486

9.  Unlocking clinical data from narrative reports: a study of natural language processing.

Authors:  G Hripcsak; C Friedman; P O Alderson; W DuMouchel; S B Johnson; P D Clayton
Journal:  Ann Intern Med       Date:  1995-05-01       Impact factor: 25.391

10.  Using OncoDoc as a computer-based eligibility screening system to improve accrual onto breast cancer clinical trials.

Authors:  Brigitte Séroussi; Jacques Bouaud
Journal:  Artif Intell Med       Date:  2003 Sep-Oct       Impact factor: 5.326

View more
  4 in total

Review 1.  Aspiring to Unintended Consequences of Natural Language Processing: A Review of Recent Developments in Clinical and Consumer-Generated Text Processing.

Authors:  D Demner-Fushman; N Elhadad
Journal:  Yearb Med Inform       Date:  2016-11-10

Review 2.  Natural Language Processing for EHR-Based Computational Phenotyping.

Authors:  Zexian Zeng; Yu Deng; Xiaoyu Li; Tristan Naumann; Yuan Luo
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2018-06-25       Impact factor: 3.710

3.  The Revival of the Notes Field: Leveraging the Unstructured Content in Electronic Health Records.

Authors:  Michela Assale; Linda Greta Dui; Andrea Cina; Andrea Seveso; Federico Cabitza
Journal:  Front Med (Lausanne)       Date:  2019-04-17

4.  Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department.

Authors:  Yizhao Ni; Stephanie Kennebeck; Judith W Dexheimer; Constance M McAneney; Huaxiu Tang; Todd Lingren; Qi Li; Haijun Zhai; Imre Solti
Journal:  J Am Med Inform Assoc       Date:  2014-07-16       Impact factor: 4.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.